Abstract:SHPT is one of the most common complications of CKD-MBD. Recent studies indicate that oxyphil cell proliferation is related to SHPT progression, while not inhibited by current treatments. The aim of this study was to analyze the correlation between oxyphil cell and clinical indicators in SHPT, further explore the protein expression differences of oxyphil cell. Among 33 MHD patients, 84.8% patients have one or more oxyphil dominant glands and the overall oxyphil cells proportion was 39.5 +/- 16.3%. Univariate correlation and multivariable linear regression model showed that oral calcitriol dosage and treatment duration were independently correlated to oxyphil cell ratio. Proteomic study showed that mitochondrial protein, protein synthesis, and cell cycle regulation were significantly altered in oxyphil cell nodules. DBP was downregulated in oxyphil nodules on protein level, which may contribute to calcitriol resistance by reducing vitamin D transport. Through KEGG and PPI network analysis, Wnt signaling, TGF-beta, ubiquitin mediated proteolysis and cell cycle pathways were significantly enriched in oxyphil cell nodules. Among which, MIF-CUL1 axis was significantly increased. These results suggest that the limitations of vitamin D in SHPT treatment is closely related to oxyphil cell and may be attributed to the dysregulation of vitamin D transport and ubiquitin regulation of oxyphil cell. Significance: Secondary hyperparathyroidism in end stage renal patients is one of the major challenges nephrology field faces. Emerging data indicate that oxyphil cell may participate in the pathophysiology of secondary hyperparathyroidism, while both calcimimetics and vitamin D receptor activators treatments are underperformed in controlling oxyphil cell proliferation. In the present study, we validated that the proliferation of oxyphil cells is associated with calcitriol treatment, and discovered that oxyphil cell nodules were significantly different from chief cells nodules in protein expression of mitochondria, protein synthesis and cell cycle regulation. It is noteworthy that DBP was downregulated in oxyphil nodules on protein level and may therefore participate in the resistance of calcitriol therapy by reducing the vitamin D transport capacity. Wnt signaling, TGF-13, ubiquitin mediated proteolysis and cell cycle pathways were significantly enriched in oxyphil cell nodules, among which, MIF-CUL1 axis may play an important role in the regulation of oxyphil proliferation and calcitriol resistance through ubiquitin mediated proteolysis. These results suggest that calcitriol treatment has limitations in oxyphil cell predominant SHPT, which may be attributed to the dysregulation of vitamin D transport and ubiquitin regulation of oxyphil cell, and the influence of microenvironment in uremia status may be the underlying reason.

NF-κB Activation Contributes to Parathyroid Cell Proliferation in Chronic Kidney Disease

Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients

Mechanism of calcitriol regulating parathyroid cells in secondary hyperparathyroidism

RNA-sequence Reveals Differentially Expressed Genes Affecting the Secondary Hyperparathyroidism

Hypermethylation of the CaSR and VDR genes in the parathyroid glands in chronic kidney disease rats with high-phosphate diet

Overexpression of Parathyroid Pituitary-Specific Transcription Factor (Pit)-1 in Hyperphosphatemia-Induced Hyperparathyroidism of Chronic Renal Failure Rats

PTH Regulation by the Klotho/FGF23 Axis in CKD

Comparative effects of calcitriol and calcimimetic on bone health in renal insufficiency

Clinical Analysis of Persistent Hypercalcemia with Osteoporosis Caused by Tertiary Hyperparathyroidism after Kidney Transplantation

Expression of the Calcium Receptor CaR in the Parathyroid of Secondary Hyperparathyroidism Patients.

Integrated transcriptomic and proteomic analyses for the characterization of parathyroid oxyphil cells in uremic patients

Comparative Proteomic Analysis of Chief and Oxyphil Cell Nodules in Refractory Uremic Hyperparathyroidism by Itraq Coupled LC-MS/MS

Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation

Activation of Nuclear Factor-Kappa B Accelerates Vascular Calcification by Inhibiting Ankylosis Protein Homolog Expression

Vitamin D supplementation in primary hyperparathyroidism: effects on 1,25(OH)2 vitamin D and FGF23 levels

Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure

Parathyroid Hormone Promotes Human Umbilical Vein Endothelial Cell Migration and Proliferation Through Orai1-Mediated Calcium Signaling

[Relationship Between Proliferation and Apoptosis of Parathyroid Cell in Rabbits with Primary Hyperparathyroidism].

High sodium promotes the secretion and synthesis of PTH through PiT-1-IKK pathway in parathyroid gland in vitro

Identification of key biomarkers based on the proliferation of secondary hyperparathyroidism by bioinformatics analysis and machine learning

Secondary Hyperparathyroidism in Chronic Kidney Disease: A Narrative Review Focus on Therapeutic Strategy